According to Inkwood Research, the Global Anticoagulants Market is predicted to register a CAGR of 8.42% in terms of revenue during the forecasting years of 2021-2028.
“Browse 44 Market Data Tables and 49 Figures spread over 206
Pages, along with an in-depth TOC on the Global Anticoagulants Market Forecast 2021-2028.”
REQUEST
CUSTOMIZATION LINK - https://www.inkwoodresearch.com/request-for-custom-report/
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/anticoagulants-market/#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://www.inkwoodresearch.com/reports/anticoagulants-market/#table-of-contents
BUY NOW- https://www.inkwoodresearch.com/reports/anticoagulants-market/
Anticoagulants, also termed as blood thinners, are
characterized as chemical substances responsible for reducing or preventing the
coagulation of blood, thereby prolonging the clotting duration. Since
anticoagulants help prevent blood clots, they are prescribed to patients with a
high risk of developing clots, while declining the chances of severe conditions
like strokes and heart attacks.
Technological
Advancements Drive Market Growth
Since anticoagulants are prescribed to patients to prevent
deep vein thrombosis and pulmonary embolism, anticoagulant therapy directed at
developing an effective and ideal anticoagulant has garnered extensive
traction. As a result, numerous attempts have been made in order to develop
novel anticoagulant delivery systems, over recent years. Recent advancements
have also played an essential role in enhancing the clinical safety and
efficacy of anticoagulants, while being beneficial across the field of
anticoagulant delivery. Moreover, advanced formulations with anticoagulants
have also displayed remarkable potential for extended prophylaxis. These newer
anticoagulants provide superior therapeutic control over coagulations, with
marginal bleeding complications. Hence, technological advancements are crucial
in driving anticoagulants market growth.
To know more about this report, request
a free sample copy.
Oral
Anticoagulants Segment to Lead the Route of Administration Category
Oral anticoagulants are available in the form of a pill or
tablet, and are administered orally. This type of anticoagulant involves newer
oral anticoagulants (NOACs) and warfarin. Among these drugs, warfarin is the
most generally prescribed oral anticoagulant. Besides, they are projected to
depict considerable growth over the forecast years, owing to the growing
awareness of NOACs and their increased adoption in emerging countries, as well
as the rising prevalence of atrial fibrillation. However, the patent expiry of
several NOACs, like Xarelto, and the risk factors linked with warfarin, are expected
to negatively impact the segment’s growth.
North
America Harbored the Largest Revenue Share in 2020
The increased levels of awareness regarding novel
therapeutics among healthcare professionals and patients, the easy availability
of therapeutics, early disease diagnosis, and the extensive presence of
hospitals and diagnostic centers, are attributed to the North America
anticoagulants market growth. Additionally, favorable reimbursement regulations
across healthcare systems, in addition to the increasing prevalence of heart
attacks, atrial fibrillation, pulmonary embolism, and deep vein thrombosis,
play an important role in driving the region’s market growth.
The industrial rivalry is expected to be intense among major
players, particularly in the process of developing innovative drugs. The
market’s pipeline products are also observing a significant increase among key
biopharmaceutical firms in multiple countries. Leading companies operating
in the global market include, Pfizer Inc, Daiichi Sankyo, Abbott Laboratories,
Bayer AG, etc.
About Inkwood
Research
Inkwood Research specializes in syndicated & customized
research reports and consulting services. Market intelligence studies with
relevant fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises of North & South America, CEE, CIS, Middle
East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
+1 857-302-4704
Related Reports:
GLOBAL
EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET
Comments
Post a Comment